MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine
Abstract Background Methyl-CpG binding domain protein 1 (MBD1), which couples DNA methylation to transcriptional repression, has been implicated in transcriptional regulation, heterochromatin formation, genomic stability, cell cycle progression and development. It has also been proven that MBD1 is i...
Main Authors: | Liu Wensheng, Zhang Bo, Hu Qiangsheng, Xu Wenyan, Ji Shunrong, Xu Jin, Ni Quanxing, Yu Xianjun, Xu Xiaowu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-09-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-019-0948-1 |
Similar Items
-
Primary malignant melanoma of gallbladder
by: Vlatka Pitlović, et al.
Published: (2011-02-01) -
Clinicopathologic and Prognostic Features in Gallbladder Malignancies: Retrospective Analysis of 5206 Cases
by: Murat Ferhat Ferhatoğlu, et al.
Published: (2019-06-01) -
Primary Malignant Melanoma of Gallbladder; an overview of its presentation, diagnosis and management
by: Jeevan Kankaria, Basavaraj Patil
Published: (2020-08-01) -
Epithelial-mesenchymal transition promotes reactivity of human lung adenocarcinoma A549 cells to CpG ODN
by: Koichi Kobayashi, et al.
Published: (2016-09-01) -
MBD2 and MBD3: elusive functions and mechanisms
by: Roberta eMenafra, et al.
Published: (2014-12-01)